Lenvatinib, LENVIDX, Lenvatinib 4mg*30 capsules

Manufacturer: Laos Daxiong Pharmaceutical

Introduction: 4mg*30 capsules

Lenvatinib is a multi-targeted receptor tyrosine kinase (RTK) inhibitor that inhibits vascular endothelial growth factor receptors (VEGFR 1-3), fibroblast growth factor receptors (FGFR1-4), platelet-derived growth factor receptor alpha (PDGFRa), KIT, and RET.

Lenvatinib can be used to treat a variety of cancers, including thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma.